Kuros Biosciences AG

BATS-CHIXE:KURNz Stock Report

Market Cap: CHF 844.1m

Kuros Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of KURNz?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3,220,2328.51%
Institutions6,390,76316.9%
Individual Insiders9,028,84323.9%
General Public19,211,80750.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 49.24% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
21.9%
C. Oomen
8,299,433CHF 185.1m0%no data
4.64%
Hatstone Fund Services Limited
1,757,777CHF 39.2m0%no data
4.64%
Global Fund Advisors Limited, Asset Management Arm
1,754,946CHF 39.1m0%98.46%
3.86%
Aldabra B.V
1,462,455CHF 32.6m0%no data
3.32%
BlackRock, Inc.
1,257,834CHF 28.0m1,990%no data
2.92%
UBS Asset Management AG
1,104,870CHF 24.6m0%no data
2.79%
Medical Strategy GmbH, Asset Management Arm
1,056,504CHF 23.6m0%1.58%
1.93%
Clemens van Blitterswijk
729,410CHF 16.3m0%no data
1.58%
Joh. Berenberg, Gossler & Co. KG, Asset Management Arm
599,272CHF 13.4m0%0.53%
0.48%
ZKB Asset Management
180,399CHF 4.0m-5.18%0.01%
0.31%
Zürcher Kantonalbank, Investment Arm
116,782CHF 2.6m4.85%0.02%
0.25%
Valiant Bank AG, Asset Management Arm
95,667CHF 2.1m46.3%0.23%
0.11%
Migrosbank Asset Management
41,461CHF 924.6k0%0.06%
0.11%
BCV Asset Management
40,000CHF 892.0k0%0.02%
0.075%
State Street Global Advisors, Inc.
28,400CHF 633.3k47.4%no data
0.058%
The Vanguard Group, Inc.
22,133CHF 493.5k0%no data
0.058%
NFS Capital AG
22,000CHF 490.6k0%0.2%
0.053%
Geode Capital Management, LLC
20,168CHF 449.7k0%no data
0.033%
Swiss Rock Asset Management AG
12,500CHF 278.7k0%0.03%
0.026%
INTERSELECT NV
10,000CHF 223.0k0%1.91%
0.022%
Lombard Odier Asset Management (Switzerland) SA
8,219CHF 183.3k0%no data
0.018%
Union Bancaire Privee, CBI-TDB, Asset Management Arm
6,985CHF 155.7k0%no data
0.016%
Baloise Asset Management
6,204CHF 138.3k0%0.01%
0.013%
Vogt Asset Management Trust Reg.
4,775CHF 106.5k0%0.1%
0.0031%
ID-Sparinvest, Filial af Sparinvest S.A., Luxembourg
1,182CHF 26.3k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/04 17:36
End of Day Share Price 2025/02/04 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Kuros Biosciences AG is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Laura Pfeifer-RossiBank am Bellevue
Olav ZilianMirabaud Securities Limited
Dylan van HaaftenNIBC Bank N.V.